Time to positive culture for solid Löwenstein–Jensen (LJ) versus liquid broth with microscopic detection.

<p>*The comparison of time to growth detection for paired 138 samples which were positive for both micro broth culture and LJ culture.</p

Results of Löwenstein–Jensen solid media and micro broth culture for patients with and without tuberculosis.

+<p>Pulmonary TB defined by American Thoracic Society.</p>*<p>Solid Löwenstein–Jensen (LJ) media.</p>×<p>Liquid broth in microplates with detection by inverted microscope.</p

Baseline Characteristics of Patients Newly Diagnosed with HIV (n = 24,925).

<p>Baseline Characteristics of Patients Newly Diagnosed with HIV (n = 24,925).</p

Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cells/mm³.

<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cells/mm³.</p

One-Year Outcomes, by Year of HIV Testing.

<p>One-Year Outcomes, by Year of HIV Testing.</p

A: Proportion of Patients with Timely, Late, or No Blood Draw for CD4 Count by Year; B: Number and Proportion of Patients Returning for CD4 Count Results by Year.

<p>A: Proportion of Patients with Timely, Late, or No Blood Draw for CD4 Count by Year; B: Number and Proportion of Patients Returning for CD4 Count Results by Year.</p

Predictors of Completing CD4 Cell Testing.

<p>Predictors of Completing CD4 Cell Testing.</p

Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count ≤350 cells/mm³.

<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count ≤350 cells/mm³.</p

Cox Proportional Hazards Model of Mortality on ART Using Gender-Specific Quartiles for Hemoglobin and Weight (Model 4).

<p>Cox Proportional Hazards Model of Mortality on ART Using Gender-Specific Quartiles for Hemoglobin and Weight (Model 4).</p

Baseline Patient Characteristics by Gender.

<p>* Two variables had ≥5% of data missing. There were 219 (10%) missing hemoglobin results for males and 279 (11%) for females. There were 200 (9%) missing CD4 count results for males and 223 (9%) for females.</p><p>**Median values and percentages are computed using the number of patients with non-missing values.</p><p>Baseline Patient Characteristics by Gender.</p